CBI books drug firm for causing loss to health dept

The company got medicine supply contract through dubious means

yash

Yash Vardhan Shukla | February 27, 2012



The Central Bureau of Investigation has registered a case against Astrazeneca pharmaceutical company which, through its director and other government and private officials, allegedly caused a loss of Rs 10 crore to the state health department. The agency has also registered a case against unknown officials of Central Procurement Agency (CPA) and Directorate of Health Service (DHS) of the Delhi government.

The CPA and the DHS had allegedly entered into Rate Contract (RC) with a private pharmaceutical company for procurement of Meropenem in 2009. Its procurement rate was fixed at Rs 1,530 plus Vat charges. The company submitted a false affidavit that none of the government, semi-government, autonomous company, public sector undertakings, hospitals, institutions and organisations got the Meropenem medicine at a lower than this rate. The company had got the supply contract through dubious means.

A show cause notice was issued to Astrazeneca by the Chief Medical Officer for recovery of Rs 7.5 crore. The company charged more from the DHS for the same medicine as compared to other agencies and authorised dealers. However, due to the connivance among the company and CPA officials, recovery proceedings were cancelled and DHS continued to purchase the medicines at a higher rate. 

The agency raided the premises of Astrazeneca in New Delhi and Bangalore. It also raided the office of CPA and DHS. It got several documents including files, hard disk, etc, which are being examined.
 

Comments

 

Other News

Not just politics, let`s discuss policies too

Why public policy matters Most days, India`s loudest debates stop at the ballot box. We can name every major leader and recall every campaign slogan. Still, far fewer of us can explain why a widow`s pension is delayed or how a government school`s budget is actually approved. That

When algorithms decide and children die

The images have not left me, of dead and wounded children being carried in the arms of the medics and relatives to the ambulances and hospitals. On February 28, at the start of Operation Epic Fury, cruise missiles struck the Shajareh Tayyebeh school – officially named a girls’ school, in Minab,

The economics of representation: Why women in power matter

India’s democracy has grown in scale, but not quite in balance. Women today are active participants in elections, influencing outcomes in ways that were not as visible earlier. Yet their presence in legislative institutions continues to lag behind. The Nari Shakti Vandan Adhiniyam was meant to addres

India will be powerful, not aggressive: Bhaiyyaji

India is poised to emerge as a global power but will remain rooted in its civilisational ethos of non-aggression and harmony, former RSS General Secretary Suresh `Bhaiyyaji` Joshi has said.   He was speaking at the launch of “Rashtrabhav,” a book by Ravindra Sathe

AI: Code, Control, Conquer

India today stands at a critical juncture in the area of artificial intelligence. While the country is among the fastest adopters of AI in the world, it remains heavily reliant on technologies developed elsewhere. This paradox, experts warn, cannot persist if India seeks technological sovereignty.

RBI pauses to assess inflation risks, policy transmission

The Reserve Bank of India (RBI) has begun the new fiscal year with a calibrated pause, keeping the repo rate unchanged at 5.25 per cent in its April Monetary Policy Committee (MPC) meeting. The decision, taken unanimously, reflects a shift from aggressive policy action to cautious observation after a signi


Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter